Tuberculosis Trial, Recruiting (NCT07369414)

Tuberculosis Trial, Recruiting NCT07369414 Sponsor: Research Center Borstel Condition: Tuberculosis

Printed from Voxsanity (voxsanity.com.au) — NCT07369414 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Tuberculosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have a confirmed diagnosis of cystic fibrosis (CF)
People of any age, including children (with consent provided by a parent or legal guardian)
People for whom written consent to take part in the study has been given (either by the person themselves, or by a parent or legal guardian for children)
People who have a certain type of lung infection called NTM (non-tuberculous mycobacteria) — if this applies, the infection must have been diagnosed using recognised medical guidelines, and a sample of the bacteria must be available for testing (confirm with trial site)

Who may not be able to join:

People who are unable to give informed consent, who do not wish to take part, or who have chosen to withdraw their consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Alexander Mischnik, Prof. Dr. med., National and WHO-Supranational Reference Center for Mycobacteria, Research Center Borstel, Leibniz Lung Center

Phone: +49 4537 / 188-7540

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07369414

Sponsor: Research Center Borstel

Phase: Not Applicable

Status: Recruiting

Condition: Tuberculosis

Trial contact: +49 4537 / 188-7540

More information: https://clinicaltrials.gov/study/NCT07369414

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have a confirmed diagnosis of cystic fibrosis (CF)
People of any age, including children (with consent provided by a parent or legal guardian)
People for whom written consent to take part in the study has been given (either by the person themselves, or by a parent or legal guardian for children)
People who have a certain type of lung infection called NTM (non-tuberculous mycobacteria) — if this applies, the infection must have been diagnosed using recognised medical guidelines, and a sample of the bacteria must be available for testing (confirm with trial site)

Who may not be able to join:

People who are unable to give informed consent, who do not wish to take part, or who have chosen to withdraw their consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Research Center Borstel

Registry

ClinicalTrials.gov

Start date

1 January 2026

Est. completion

1 December 2028

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Prevalence of NTM in environmental samples; Difference in NTM prevalence between case and control groups; Genetic concordance between environmental and patient isolates

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov